COMMUNIQUÉS West-GlobeNewswire

Privia Health to Report First Quarter 2026 Results on Thursday, May 7
08/04/2026
ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on [...]
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
08/04/2026
PRINCETON, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its [...]
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
08/04/2026
Enrolling Phase 2 DAYBreak CLL-201 bexobrutideg trial designed to support Accelerated Approval in relapsed/refractory chronic lymphocytic leukemia (r/r CLL) Enabling Phase 3 DAYBreak CLL-306 bexobrutideg confirmatory [...]
Clariane annonce l’offre de 500 millions d’euros d’obligations senior en vue de refinancer une partie de son endettement existant
08/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
08/04/2026
66.7% of participants achieved an antidepressant response by Day 2 following a single intranasal dose of BPL-003 in both the 10 mg (n=6) and 12 mg (n=6) cohorts Durable responses observed at Day 85: 83% (5/6) (10 mg) [...]
Zelluna ASA – Disclosure of voting rights of Annual General Meeting
08/04/2026
Oslo, April 8, 2026: In connection with the Annual General Meeting of Zelluna ASA to be held on April 23, 2026, Anders Tuv, Chair of the Board of Directors, has, as of the date of this announcement, received proxy-based [...]
Clariane has launched a proposed offering of €500 million of senior notes to refinance part of its existing indebtedness
08/04/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane has [...]
Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby
08/04/2026
MELBOURNE, Australia and OXFORD, United Kingdom, April 08, 2026 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today [...]
Novonesis expands global footprint with acquisition of production facility in Southeast Asia
08/04/2026
Novonesis expands global footprint with acquisition of production facility in Southeast Asia Investment of around USD 50 million strengthens fermentation capabilities and supports the company’s long-term growth [...]
Fortrea dévoile Fortrea Intelligent Technology™ : une technologie destinée à permettre aux investigateurs et aux centres d’essais cliniques de mener des essais plus intelligents et mieux intégrés
08/04/2026
Cette offre de solutions optimisée par l’IA s’appuie sur une technologie innovante et perfectionnée visant à renforcer l’efficacité, la fiabilité et la qualité Points clés : Une solution conçue pour révolutionner les [...]
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy
08/04/2026
Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients ~15,000 children are living with DMD in the U.S. NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Mesoblast [...]
DERMAdoctor Announces Initiative to Broaden Public Access to Dermatologist-Developed Clinical Skincare
08/04/2026
Davie, FL, April 08, 2026 (GLOBE NEWSWIRE) -- DERMAdoctor , the clinical skincare company founded by board-certified dermatologist Dr. Audrey Kunin, announced today that it is undertaking a renewed initiative designed [...]
Jelly Lean Gummies Under Investigation: Evaluating the Homemade Jelly Burn Gelatin Trick Recipe Formulation Claims (Avoid Scam Risks)
08/04/2026
A 2026 informational overview providing context on increased search activity around JellyLean gummies, the homemade gelatin trick recipe trend, jelly burn weight loss hack variations, whether JellyLean is legit, full [...]
Leanzene Claims Evaluated: The Leading Keto BHB + ACV Weight Loss Gummy Brand on the Market
08/04/2026
A 2026 informational consumer evaluation of Leanzene's keto BHB gummy and apple cider vinegar weight loss formula, ingredient research context, proprietary blend label transparency, and what men and women should verify [...]
Gelatin Trick Recipe Under Investigation: The Viral Doctor-Approved Jello Weight Loss Hack Claims Evaluated for Gelatide Drops
07/04/2026
An informational 2026 consumer overview examining the gelatin trick recipe trend, pink gelatin trick variations, whether Gelatide Drops is legit, full Gelatide ingredient and dosage transparency analysis, Gelatide-1 [...]
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference
07/04/2026
SAN CARLOS, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in a fireside chat at the 25th [...]
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
07/04/2026
MOUNTAIN VIEW, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the [...]
BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026
07/04/2026
LOUISVILLE, Ky., April 07, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2026 financial results [...]
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
07/04/2026
Cohealyx ® multi-center study interim analysis and new case data to be presented RECELL ® and PermeaDerm ® data reinforce a comprehensive approach to wound healing Evidence demonstrates potential to improve outcomes [...]

Pages